Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [41] Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
    Liu, Yang
    Chen, Wei
    Yu, Mingxiao
    Li, Hujun
    Cheng, Hai
    Cao, Jiang
    Yan, Zhiling
    Shi, Ming
    Zhu, Feng
    Sun, Haiying
    Sang, Wei
    Li, Depeng
    Wu, Qingyun
    Chen, Chong
    Zheng, Junnian
    Xu, Kailin
    Li, Zhenyu
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02): : 118.e1 - 118.e5
  • [42] Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma
    Rodriguez Gil de Montes, Angibelle Lizmar
    Spencer, Lilian Maritza
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (11) : 1261 - 1269
  • [43] Donor-derived CD19 chimeric antigen receptor T cells
    Singh, Nathan
    Barrett, David M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 503 - 508
  • [44] Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma
    Steinbach, Mary
    Zitella, Laura J.
    Florendo, Erika
    Lee, Erin
    Riccobono, Carrie
    DiFilippo, Heather
    Aronson, Elizabeth
    SEMINARS IN ONCOLOGY NURSING, 2023, 39 (06)
  • [45] Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
    Garcia-Guerrero, Estefania
    Sierro-Martinez, Belen
    Perez-Simon, Jose Antonio
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
    Pont, Margot J.
    Hill, Tyler
    Cole, Gabriel O.
    Abbott, Joe J.
    Kelliher, Jessica
    Salter, Alexander I.
    Hudecek, Michael
    Comstock, Melissa L.
    Rajan, Anusha
    Patel, Bharvin K. R.
    Voutsinas, Jenna M.
    Wu, Qian
    Liu, Lingfeng
    Cowan, Andrew J.
    Wood, Brent L.
    Green, Damian J.
    Riddell, Stanley R.
    BLOOD, 2019, 134 (19) : 1585 - 1597
  • [47] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [48] Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma
    Yang, Xu
    Wang, Feiqing
    Yuan, Xiaoshuang
    Yang, Bo
    Chen, Juan
    Cheng, Jinyang
    Liu, Guangyang
    Tang, Dongxin
    Xu, Xiao
    Wang, Sanbin
    He, Zhixu
    Liu, Yang
    Li, Yanju
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
    Liqing Kang
    Jian Zhang
    Minghao Li
    Nan Xu
    Wei Qi
    Jingwen Tan
    Xiaoyan Lou
    Zhou Yu
    Juanjuan Sun
    Zhenkun Wang
    Chengcheng Fu
    Xiaowen Tang
    Haiping Dai
    Jia Chen
    Depei Wu
    Lei Yu
    Biomarker Research, 8
  • [50] Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma
    Jiang, Dongpeng
    Huang, Haiwen
    Qin, Huimin
    Tang, Koukou
    Shi, Xiangru
    Zhu, Tingting
    Gao, Yuqing
    Zhang, Ying
    Tian, Xiaopeng
    Fu, Jianhong
    Qu, Weiwei
    Cai, Weilan
    Xu, Yang
    Wu, Depei
    Chu, Jianhong
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345